Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bégaud, Bernard
297  Ergebnisse:
Online X
Personensuche X
?
1

The Reporting of a Disproportionality Analysis for Drug Saf..:

Fusaroli, Michele ; Salvo, Francesco ; Begaud, Bernard...
Drug Safety.  47 (2024)  6 - p. 575-584 , 2024
Link: https://doi.org/10.1007/..
 
?
2

The REporting of A Disproportionality Analysis for DrUg Saf..:

Fusaroli, Michele ; Salvo, Francesco ; Begaud, Bernard...
Drug Safety.  47 (2024)  6 - p. 585-599 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Trajectories of Benzodiazepine Use among Older Adults from ..:

Maumus-Robert, Sandy ; Jarne-Munoz, Ana ; Tournier, Marie..
Drugs & Aging.  40 (2023)  10 - p. 919-931 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Drugs and the elderly: A complex interaction:

Bégaud, Bernard ; de Germay, Sybille ; Noize, Pernelle
Therapies.  78 (2023)  5 - p. 559-563 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Alzheimer disease: Leave no stone unturned:

Bégaud, Bernard
European Journal of Neurology.  29 (2022)  5 - p. 1289-1290 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Neurocognitive Disorders Associated with PCSK9 Inhibitors: ..:

Gouverneur, Amandine ; Sanchez-Pena, Paola ; Veyrac, Gwenaelle...
Cardiovascular Drugs and Therapy.  37 (2021)  2 - p. 271-276 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Anticholinergic Activity of Psychotropic Drugs and Cognitiv..:

Ziad, Abdelkrim ; Berr, Claudine ; Ruiz, Fabrice...
Drug Safety.  44 (2021)  5 - p. 565-579 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Decongestant use and the risk of myocardial infarction and ..:

Grimaldi-Bensouda, Lamiae ; Begaud, Bernard ; Benichou, Jacques...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

DPP-4 Inhibitors in Combination with Lipid-Lowering Agents ..:

Pariente, Antoine ; Labat, Vanessa ; Mansiaux, Yohann...
Drug Safety.  43 (2020)  8 - p. 767-774 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Benefit–Risk Assessment of Vaccines. Part I: A Systematic R..:

Arlegui, Hugo ; Bollaerts, Kaatje ; Salvo, Francesco...
Drug Safety.  43 (2020)  11 - p. 1089-1104 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towa..:

Arlegui, Hugo ; Bollaerts, Kaatje ; Bauchau, Vincent...
Drug Safety.  43 (2020)  11 - p. 1105-1120 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Using Discretely Integrated Condition Event Simulation To C..:

Arlegui, Hugo ; Nachbaur, Gaëlle ; Praet, Nicolas..
Clinical Therapeutics.  42 (2020)  10 - p. 1983-1991.e2 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Medicine misuse: A systematic review and proposed hierarchi..:

Singier, Allison ; Noize, Pernelle ; Berdaï, Driss...
British Journal of Clinical Pharmacology.  87 (2020)  4 - p. 1695-1704 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Quantitative Benefit-Risk Models Used for Rotavirus Vaccina..:

Bégaud, Bernard ; Praet, Nicolas ; Nachbaur, Gaëlle.
Open Forum Infectious Diseases.  7 (2020)  4 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
15

Overview of French databases available for studying antican..:

Casarotto, Emilie ; Noize, Pernelle ; Gouverneur, Amandine...
Fundamental & Clinical Pharmacology.  35 (2020)  1 - p. 76-85 , 2020
Link: https://doi.org/10.1111/..
 
1-15